749
Views
8
CrossRef citations to date
0
Altmetric
Reviews

Safety and tolerability of anticonvulsant medication in bipolar disorder

, MD, , MD, , MD & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Heinz Grunze & Michael Soyka. (2022) The pharmacotherapeutic management of comorbid bipolar disorder and alcohol use disorder. Expert Opinion on Pharmacotherapy 23:10, pages 1181-1193.
Read now
Lingli Kong, Tiantian Zhou, Bailing Wang, Zhenbo Gao & Chunxia Wang. (2018) The risks associated with the use of lamotrigine during pregnancy. International Journal of Psychiatry in Clinical Practice 22:1, pages 2-5.
Read now

Articles from other publishers (6)

Caitlin S. Yee, Gustavo H. Vázquez, Emily R. Hawken, Aleksandar Biorac, Leonardo Tondo & Ross J. Baldessarini. (2021) Long-Term Treatment of Bipolar Disorder with Valproate: Updated Systematic Review and Meta-analyses. Harvard Review of Psychiatry 29:3, pages 188-195.
Crossref
Claudia Pisanu, Alessio Squassina, Martin Alda & Giovanni Severino. 2020. Personalized Psychiatry. Personalized Psychiatry 393 402 .
M. Reich & X. Bondenet. (2018) Place des psychotropes en oncologie. Psycho-Oncologie 12:2, pages 114-130.
Crossref
Stacy M. Ku & Ming-Hu Han. (2017) HCN Channel Targets for Novel Antidepressant Treatment. Neurotherapeutics 14:3, pages 698-715.
Crossref
Daniel Bertrand, Bruno Biton, Thomas Licher, Jean‐Marie Chambard, Christophe Lanneau, Michel Partiseti & Isabel A. Lefevre. (2016) Functional Studies of Sodium Channels: From Target to Compound Identification. Current Protocols in Pharmacology 75:1.
Crossref
Rintaro SogawaSakiko MochinagaTakayoshi InabaJun MatsushimaYoshito MizoguchiToshiro KawashimaHiroshi FujitoAkira Monji. (2016) Safety of Long-term Use of Lamotrigine for the Treatment of Psychiatric Disorders. Clinical Neuropharmacology 39:6, pages 295-298.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.